{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:57:53Z","timestamp":1790690273291,"version":"4.1.0"},"reference-count":23,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institut National du Cancer (INCa), the Ligue Contre le Cancer (Equipe Labellis\u00e9e Ligue), the Comit\u00e9 Orientation Recherche Cancer (CORC), the Limousin Region and the Haute Vienne and Corr\u00e8ze committees of the Ligue Nationale contre le Cancer and by the Lyons Club de Corr\u00e8ze"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>While studying c-Myc protein expression in several Burkitt lymphoma cell lines and in lymph nodes from a mouse model bearing a translocated c-MYC gene from the human BL line IARC-BL60, we surprisingly discovered a complex electrophoretic profile. Indeed, the BL60 cell line carrying the t(8;22) c-MYC translocation exhibits a simple pattern, with a single c-Myc2 isoform. Analysis of the c-MYC transcripts expressed by tumor lymph nodes in the mouse \u03bbc-MYC (Avy\/a) showed for the first time five transcripts that are associated with t(8;22) c-MYC translocation. The five transcripts were correlated with the production of c-Myc2 and c-MycS, and loss of c-Myc1. The contribution of these transcripts to the oncogenic activation of the t(8;22) c-MYC is discussed.<\/jats:p>","DOI":"10.3390\/biom12060836","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:48:12Z","timestamp":1655430492000},"page":"836","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1255-4241","authenticated-orcid":false,"given":"Dina","family":"Ibrahim","sequence":"first","affiliation":[{"name":"CNRS UMR-7276, INSERM U1262, CRIBL, Dupuytren Hospital University Center (CHU) of Limoges, University of Limoges, 87036 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Pr\u00e9vaud","sequence":"additional","affiliation":[{"name":"CNRS UMR-7276, INSERM U1262, CRIBL, Dupuytren Hospital University Center (CHU) of Limoges, University of Limoges, 87036 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Faumont","sequence":"additional","affiliation":[{"name":"CNRS UMR-7276, INSERM U1262, CRIBL, Dupuytren Hospital University Center (CHU) of Limoges, University of Limoges, 87036 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Troutaud","sequence":"additional","affiliation":[{"name":"CNRS UMR-7276, INSERM U1262, CRIBL, Dupuytren Hospital University Center (CHU) of Limoges, University of Limoges, 87036 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Feuillard","sequence":"additional","affiliation":[{"name":"CNRS UMR-7276, INSERM U1262, CRIBL, Dupuytren Hospital University Center (CHU) of Limoges, University of Limoges, 87036 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Diab-Assaf","sequence":"additional","affiliation":[{"name":"Department of Sciences, Lebanese University Fanar, Beirut 1500, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Oulmouden","sequence":"additional","affiliation":[{"name":"CNRS UMR-7276, INSERM U1262, CRIBL, Dupuytren Hospital University Center (CHU) of Limoges, University of Limoges, 87036 Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.physiol.60.1.575","article-title":"The many roles of c-Myc in apoptosis","volume":"60","author":"Thompson","year":"1998","journal-title":"Annu. Rev. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(88)90507-7","article-title":"A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt\u2019s lymphomas","volume":"52","author":"Hann","year":"1988","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1128\/MCB.17.3.1459","article-title":"Identification of downstream-initiated c-Myc proteins which are dominant- negative inhibitors of transactivation by full-length c-Myc proteins","volume":"17","author":"Spotts","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0065-230X(07)99004-1","article-title":"The c-myc promoter: Still MysterY and challenge","volume":"99","author":"Wierstra","year":"2008","journal-title":"Adv. Cancer Res."},{"key":"ref_5","first-page":"1397","article-title":"Expression of P0-and P3-RNA from the normal and translocated c-myc allele in Burkitt\u2019s lymphoma cells","volume":"5","author":"Eick","year":"1990","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1101\/gad.8.20.2441","article-title":"The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site","volume":"8","author":"Hann","year":"1994","journal-title":"Genes Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1128\/MCB.25.22.9897-9909.2005","article-title":"Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster","volume":"25","author":"Benassayag","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1074\/jbc.M611437200","article-title":"A conserved pathway that controls c-Myc protein stability through opposing phosphorylation events occurs in yeast","volume":"282","author":"Sears","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"El\u017cbieta Kasprzyk, M., Sura, W., and Dzikiewicz-Krawczyk, A. (2021). Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer. Cancers, 13.","DOI":"10.3390\/cancers13133270"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ng1177","article-title":"Spatial proximity of translocation-prone gene loci in human lymphomas","volume":"34","author":"Roix","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.onc.1202468","article-title":"Deregulation of the proto-oncogene c-myc through t(8; 22) translocation in Burkitt\u2019s lymphoma","volume":"18","author":"Gerbitz","year":"1999","journal-title":"Oncogene"},{"key":"ref_12","first-page":"65","article-title":"Constitutive C-myc overexpression and p1\/p2 promoter shift in a small-cell lung-cancer cell-line","volume":"5","author":"Dooley","year":"1994","journal-title":"Int. J. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3389\/fimmu.2020.01564","article-title":"Mouse models of c-myc deregulation driven by IgH locus enhancers as models of B-cell lymphomagenesis","volume":"11","author":"Ferrad","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse","volume":"192","author":"Kovalchuk","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.3685977","article-title":"Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma","volume":"238","author":"Cesarman","year":"1987","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bayda, B., Tilloy, V., Chaunavel, A., Bahri, R., Halabi, M.A., Feuillard, J., Jaccard, A., and Ranger-Rogez, S. (2021). Comprehensive Epstein-Barr Virus Transcriptome by RNA-Sequencing in Angioimmunoblastic T Cell Lymphoma (AITL) and Other Lymphomas. Cancers, 13.","DOI":"10.3390\/cancers13040610"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1158\/0008-5472.CAN-12-4063","article-title":"MYC phosphorylation at novel regulatory regions suppresses transforming activity","volume":"73","author":"Wasylishen","year":"2013","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1093\/nar\/17.16.6499","article-title":"Analysis of polyadenylation site usage of the c-myc oncogene","volume":"17","author":"ElfTerich","year":"1989","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1202927","article-title":"Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately","volume":"18","year":"1999","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/nar\/gkx1114","article-title":"Complete motif analysis of sequence requirements for translation initiation at non-AUG start codons","volume":"46","author":"Noderer","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/cdd.2016.91","article-title":"Alternative splicing and cell survival: From tissue homeostasis to disease","volume":"23","author":"Paronetto","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1084\/jem.20020179","article-title":"\u0394Np73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up- regulated in human tumors","volume":"196","author":"Zaika","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1038\/s41388-021-02053-4","article-title":"Selective targeting of MYC mRNA by stabilized antisense oligonucleotides","volume":"40","author":"Gill","year":"2021","journal-title":"Oncogene"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/6\/836\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:32:43Z","timestamp":1760139163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/6\/836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["biom12060836"],"URL":"https:\/\/doi.org\/10.3390\/biom12060836","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.18.480896","asserted-by":"object"}]},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]}}}